Mutants of Escherichia coli K12 constitutive for the fatty acid /I-oxidation pathway (oleR mutation) have a septum-formation deficiency at high growth rates and there is at the same time a perturbation of the phospholipid ratio (phosphatidylglycerol/cardiolipin) that characterizes E. colicells in fast-growth condition (Vanderwinkel et al., 1976) . We report here a new element in the relationship that could exist between growth rate, phospholipid composition and septum-formation ability; the oleR regulatory mutation also leads to a spontaneous murein-hydrolytic activity.
Hartmann et al. (1974) have shown that murein hydrolases are normally inactive in intact cells of Escherichia coli, and can be released by various pretreatments, such as osmotic shock, incubation in presence of EDTA or even of trichloroacetic acid; they conclude that these membrane-bound hydrolases are normally prevented from uncontrolled reaction on their natural substrate, the mucopeptide sacculus, the shapemaintaining macromolecule of the bacterial cell envelope. When tested under the conditions described by the above authors, our mutant cells liberate 2,6-diarnin0[~H]-pimelic acid-containing material without any preactivating treatment; the parent strain, as expected, requires such treatment. Table 1 shows that the release of murein hydrolase activity was only found in mutant cells growing exponentially at high rates on rich medium, and not when growing on glucose/mineral-salts medium; this behaviour thus appears to be concomitant with both the phospholipid perturbation and the septum-formation deficiency we described previously.
The soluble diaminopimelic acid-containing material liberated can be eluted with 0.01 M-acetic acid from coupled columns of Sephadex G-25 and G-50 in two peaks of a material with a polypeptide nature; no hexosamine is detectable in either of them; the major-peak material has a mol.wt. of about 5000. Amino acid-composition analysis of this fraction reveals the presence (in particular) of alanine, glutamic acid and diaminopimelic acid; valine, glycine, isoleucine and leucine have also been found. T. I. c. (Morse & Horecker, 1966) of the hydrolysate of the dansyl (5-dimethylaminonaphthalene-1-sulphony1)ated derivative (Gray, 1967) clearly indicates alanine as the N-terminal amino acid of this liberated murein-hydrolysis product.
Thus among the presently known murein hydrolases it is the N-acetylmuramoyl-Lalanine amidase which very probably is abnormally activated in the mutant cell in the condition of septum-formation deficiency. Wolf-Watz & Normark (1 976) showed a decrease in the activity of this enzyme in an enuA mutant of Exherichin coli K12 which is known to have septum-separation deficiency.
VOl. 5 or not (with activation treatment or not) in 10mM-Tris/maleate buffer, pH6.0/10m~-MgSO,, containing 1 M-NaCI, and allowed to react in an icebath. In each case cells were washed three times with cold lomM-Tris/maleate buffer, pH6.0/10m~-MgSO~ and resuspended in the same buffer at A660 = 0.450. As a reference, radioactivity was measured in portions of cell suspension. The suspension was incubated at 37°C; portions (0.5ml) were withdrawn at different times and poured into centrifuge tubes prewarmed at 100°C; a 0.04ml portion of aq.
2.5
% (w/v) serum albumin was added; after 5min in boiling water, tubes were cooled in an ice bath, and centrifuged at 12000g for 10min. The radioactivity of the supernatant was measured in a Triton/dioxane scintillation mixture. A variety of mucopolysaccharidoses are known to exist, depending on the type of glycosaminoglycan accumulated (McKusick et al., 1965) . Recent studies point to a deficiency of specific degradative enzymes (Constantopoulos & Dekaban, 1975) . The mucopolysaccharides stored in tissues have only occasionally been analysed (Phillipart, 1972; Van Hoof, 1973) . We have reported the lipid composition of brain and viscera in two cases (L.L. and D.C.) of mucopolysaccharidosis showing the clinical features of Sanfilippo disease (Van Dessel et al., 1976) . The present communication deals with the mucopolysaccharide composition in those patients. The tissues were first defatted by using chloroform/methanol mixtures at various ratios (by volume). The delipidated residues were further subjected to proteolytic digestion with papain or Pronase, whereafter the glycosaminoglycans were precipitated from the supernatant with cetylpyridinium chloride. Total mucopolysaccharide concentration was determined by the carbazole method as modified by Bitter & Muir (1962) , with glucuronolactone as a standard. Iduronic acid was assayed by the naphthoresorcinol method (Teller, 1967) . The analysis of the N-substituted hexosamines was performed in an amino acid analyser (Van Dessel et al., 1975) . The electrophoretic patterns of the mucopolysaccharides on cellulose acetate were obtained by the procedure of Wessler (1968) .
The colorimetric determination of uronic acid (Table 1) indicated an increase in glycosaminoglycan in all tissues (not in the brain of D.C.), being most pronounced in the liver. The N-substituted hexosamines were also present in much higher concentrations with regard to the control value (except for the brain of D.C.). In the patients' tissues only the presence of N-substituted glucosamine could be demonstrated, whereas in the control an average value of 3:2 was calculated for the molar ratio of N-substituted glucosaminelN-substituted galactosamine.
Electrophoresis of mucopolysaccharides on cellulose acetate in barium acetate buffer showed, for the viscera, an intense spot migrating ahead of the heparin standard, but clearly moving more slowly than the hyaluronic acid, chondroitin 4-sulphate, chondroitin 6-sulphate and dermatan sulphate standards. The electrophoretic behaviour of heparan sulphate (Wessler, 1968) is very similar to that of the unknown spot. The presence of the same component could also be demonstrated in brain, but hyaluronic acid still remained the main constituent. Densitometric measurementsof the electrophoretograms showed a 3-(viscera) to 10-fold (brain) increase in the percentage distribution of heparan sulphate in the mucopolysaccharide pattern. From these results VOl. 5
